Researchers identify cellular stress-protection system that may help tumors withstand chemotherapy
· Medical Xpressby Lesley Henton, Texas A&M University
edited by Lisa Lock, reviewed by Andrew Zinin
Lisa Lock
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Many cancer treatments work by exploiting weaknesses in tumor cells, overwhelming their ability to survive, repair damage or continue growing. Yet some cancer cells manage to survive treatment. A new study from Texas A&M University sheds light on one reason why: Some cancer cells have a survival toolkit.
The research team, led by Dr. Wenshe Liu, Regents Professor and Harry E. Bovay Jr. Chair in chemistry in the College of Arts and Sciences, has identified key components of a little-understood cellular pathway that appears to help cells cope with oxidative stress, a form of molecular damage triggered by normal metabolism—and many cancer treatments. The study, published in Nature Communications, suggests that blocking this protective system could make certain therapies more effective against cancer.
A hidden pathway revealed
Researchers focused on a protein called URM1, which has remained something of a mystery despite being conserved across evolution, from simple organisms such as yeast to humans. Scientists already knew URM1 plays a role in helping cells respond to stress, but the molecular machinery that controls the pathway in human cells had not been identified.
"This pathway has been retained across species for hundreds of millions of years, which suggests it serves an important biological function," Liu said. "Our findings reveal how the pathway is activated in human cells and establish the molecular players that make it work."
To uncover how the system operates, the researchers developed a specialized molecular probe capable of capturing proteins involved in URM1 activity. Using that tool, they identified two enzymes, NAE1/UBA3 and UBE2M, that drive the URM1 modification process in human cells.
The study showed that disrupting either enzyme sharply reduced URM1 activity. The same effect was observed when cells were treated with compounds that inhibit the enzymes, providing additional evidence that NAE1/UBA3 and UBE2M serve as central regulators of the pathway.
The team also found that oxidative stress strongly activates URM1, placing the pathway among the cellular systems mobilized when cells encounter damaging conditions. Together, the findings provide the clearest picture yet of how the URM1 pathway is activated and controlled in human cells.
Why the discovery could matter for cancer treatment
Many anticancer drugs work, at least in part, by overwhelming tumor cells with damage and oxidative stress. Understanding how cells adapt to those conditions could reveal new ways to make treatments more effective.
To explore that possibility, the researchers examined what happened when the URM1 pathway was disabled. Cells lacking URM1 activation were significantly less likely to survive oxidative stress than normal cells, suggesting the pathway helps buffer cells against damage.
"These results suggest that URM1 helps cells withstand stressful conditions," Liu said. "If we can selectively interfere with that protection in cancer cells, we may be able to improve the effectiveness of treatments that already rely on generating stress inside tumors."
Because drugs that target NAE1/UBA3 are already being investigated in cancer research, the findings raise the possibility that existing therapeutic strategies could also affect the newly identified URM1 pathway. The researchers say additional studies are needed to determine whether targeting the pathway can enhance cancer treatments while minimizing effects on healthy cells.
Existing drugs may offer a shortcut
One of the study's most intriguing findings involved pevonedistat, an experimental drug that inhibits NAE1/UBA3, which helps activate URM1. The researchers discovered that the drug blocks URM1 activity and works especially well when combined with cisplatin, a chemotherapy drug known to induce oxidative stress. Together, the two treatments killed liver cancer cells more effectively than either treatment alone.
The findings raise the possibility that some drugs originally developed for other cellular pathways could be repurposed or combined with existing cancer therapies. However, the researchers note that additional studies will be needed to determine exactly how the pathway functions in patients and whether it can be safely targeted.
New clues for future cancer therapies
The study also found that high URM1 expression was associated with poorer outcomes among patients with liver cancer, suggesting the pathway may help tumors adapt to stressful conditions and continue growing.
According to Liu, the work opens the door to a new area of investigation. "We still have much to learn about which proteins are controlled by URM1 and how that influences disease," Liu said. "But identifying the key enzymes behind this pathway gives researchers a clearer roadmap for exploring its role in cancer and other diseases linked to cellular stress responses."
Publication details
Swatadipta Chakraborty et al, NAE1/UBA3-UBE2M are E1 and E2 enzymes for the URM1 modification, Nature Communications (2026). DOI: 10.1038/s41467-026-72296-w
Journal information: Nature Communications
Key medical concepts
Clinical categories
OncologyClinical pharmacology Provided by Texas A&M University Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Researchers identify cellular stress-protection system that may help tumors withstand chemotherapy (2026, September 23) retrieved 23 September 2026 from https://medicalxpress.com/news/2026-09-cellular-stress-tumors-chemotherapy.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.